Navigation Links
Collexis BiomedExperts Hits 80,000 Registered Users Within the First Year!

COLUMBIA, S.C., Jan. 7 /PRNewswire-FirstCall/ -- Collexis Holdings Inc. (OTC Bulletin Board: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that their life science research portal has surpassed 80,000 registered users. The unique visitor traffic in December has exploded to over 60,000 per day and surpassed 1.4 million unique visitors in December!

(Logo: )

"We are very pleased with the user registration growth of BiomedExperts as well as the accolades that we are receiving from the industry," stated Bill Kirkland, CEO of Collexis Holdings, Inc. "As our user registration base grows along with our page views, BiomedExperts is poised to become the industry standard for life science researchers. We are looking forward to the future releases of BiomedExperts and the launch of new portals across the other scientific disciplines and industries."

Research and advisory firm Outsell, Inc. selected BiomedExperts as one of the top 10 social communities to watch in 2009, in its report "Social Media in STM Part 1: Social Networking" ( A recent Elsevier study found after only seven months post launch, BiomedExperts was the second most frequently used life science social network behind Nature but ahead of Facebook, MySpace and LinkedIn. Also the launch announcement of BiomedExperts was the #1 headline on the eHealthNews.EU news portal for 2008.

Pre-populated with over 1.8 million Pub-Med-based expert profiles, BiomedExperts allows scientists and researchers to directly connect with and explore their own professional contacts, grow their networks and identify researchers with the expertise needed for future collaborations. Through user-friendly search interfaces, potential research collaborators can share data and collaborate with professionals from more than 1,800 organizations and institutions from 137 countries, totaling more than 21 million connections made through the site.

About Collexis Holdings, Inc.

Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with operations in Cincinnati, Ohio and Cologne, Germany. Collexis now offers the world's first pre-populated scientific social network for life science researchers, . Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit .

Forward-Looking Statements

Some of the statements made in this press release may constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to differ materially from any future results or performance expressed or implied by such forward- looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with These risks and uncertainties are in addition to other factors detailed from time to time in the company's filings with the SEC, including the section entitled "Risk Factors" in its transition report on Form 10-KSB for the period ended June 30, 2008. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.

SOURCE Collexis Holdings Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Collexis Launches Innovative Reviewer Finder to Enhance the $30 Billion Health Research Grant Industry
2. Collexis Healthcare to Expand Capabilities for Asklepios Group Utilizing Microsoft Solutions
3. Mayo Clinic to Pilot Collexis Expert Profiling
4. Dental Services Expand to Serve More Than 280,000 Michigan Children
5. Anthem Blue Cross and Blue Shield Foundation and Plan Associates Pledge More Than $880,000 to Community Organizations in 2008
6. Coalition for Pulmonary Fibrosis Fundraising Events Raise $280,000 for IPF
7. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
8. Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants
9. Registered Nurses Ratify 3-year Agreement With University Hospitals Geneva Medical Center
10. University Hospitals Geneva Medical Center Registered Nurses to Strike on December 10 if Contract Agreement Cannot Be Reached
11. Riverside County Registered Nurses File a Lawsuit to Stop Countys Violation of Federal Law
Post Your Comments:
(Date:12/1/2015)... Angeles, CA (PRWEB) , ... December 01, 2015 , ... ... United States, today announced that its iconic bottle has won top honors in Beverage ... category. The Company also announced that it has been selected as a 2015 ...
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation ... utilization of hospital and nonhospital care, according to a recent study by the Workers ... 16th Edition , found medical payments per claim with more than seven days of ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today ... Golden Bridge Business Awards under the New Products and Services category for its ... sample management software that helps labs organize data and track samples ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic ... United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a ... catastrophic contributors to diseases of the diabetic foot. The American Board of ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... keeping their independence is everything. That is why Hollister Incorporated has launched the ... to offer this next product in the VaPro touch free catheter portfolio,” said ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... FREMONT, Calif. , Dec. 1, 2015 ... identify the Top 10 Clinical Data Management Solution ... of entries, a distinguished panel comprising CEOs, CIOs, VCs, ... Velos in the illustrious list of top 10 clinical ... and the article on pages 14 and 36 respectively). ...
(Date:12/1/2015)... 1, 2015 Assurex Health, Inc. today ... giving healthcare providers an expanded range of options ... suffering from depression, anxiety, bipolar disorder, posttraumatic stress ... i .   --> ... the addition of two new drug classes, 17 ...
(Date:12/1/2015)... VERONA, Va. , Dec. 1, 2015 /PRNewswire/ ... today unveiled a new corporate logo and brand ... in the design and engineering of bladed products ... --> --> Serving ... fiber, glass, and auto glass equipment, AccuTEC,s product ...
Breaking Medicine Technology: